VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MKLMarkel Corporation
$1920.06$24.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMKLCash Flow

Markel Corporation (MKL) Cash Flow Statement

30Y historyFree accessUpdated daily

Operating cash flow has deteriorated sharply to $15.9 million in 2026Q1, resulting in a negative OCF/NI ratio of -0.07 that highlights a disconnect between reported earnings and actual cash generation.

MKL Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations2.4B2.76B2.59B2.79B2.71B2.27B1.74B1.27B892.86M858.53M534.62M651.15M716.79M745.52M392.53M311.32M223.29M282.46M390.16M508.32M511.59M551.25M690.69M631.45M507.37M164.47M89.21M558K39.9M68.6M94.4M
Operating CF Growth %-37.75%6.45%-6.92%2.86%19.15%30.88%36.38%42.7%4%60.59%-17.9%-9.16%-3.85%89.93%26.09%39.42%-20.95%-27.6%-23.25%-0.64%-7.19%-20.19%9.38%24.46%208.49%84.35%15887.99%-98.6%-41.84%-27.33%-44.14%
Operating CF / Revenue %14.49%16.64%15.49%17.74%22.94%17.6%18.03%13.38%12.85%14.16%9.53%12.13%13.96%17.25%13.08%11.84%10.03%13.65%19.74%20.47%20.31%25.06%30.53%30.19%28.66%11.77%8.15%0.11%9.37%16.37%25.74%
Net Income1.77B2.11B2.85B2.1B-101.2M2.45B831.77M1.8B-130.35M400.76M460.44M589.14M323.69M283.85M258.25M148.49M267.73M202.42M-58.77M405.67M392.5M147.91M165.41M123.48M75.32M-125.72M-27.59M40.61M57.3M50.4M46.7M
Depreciation & Amortization00342.36M259.92M366.95M336.39M307.07M269.24M227.85M203.87M194.15M200.99M203.58M190.07M87.33M70.57M53.59M31.17M28.67M30.53M27.61M29.58M31.34M39.26M28.23M41.91M32.4M12.86M7.3M7.3M10.9M
Stock-Based Compensation00000000011.9M14.3M16.3M18.7M18.4M4.4M0000000000000000
Deferred Taxes00394.56M233.8M-281.75M453.41M-2.73M323.38M2.73M-324.09M63.36M-9.68M84.54M4.05M37.65M5.65M7.18M-9.14M-100.42M31.93M30.56M-44.51M-29.8M-13.22M-3.47M-76.2M-18.1M9.48M7M-600K-15.3M
Other Non-Cash Items587.55M-379.35M-2.06B-1.41B1.53B-1.88B-494.68M-1.55B-25.17M20.85M43.46M67.41M-13.83M13.98M-21.93M26.16M-36.36M96.1M407.59M31.38M-220.02M-37.33M-59.16M-143.16M-1.18M311.37M106.99M-68.2M-26.8M-22.5M-29.3M
Working Capital Changes01.03B1.07B1.61B1.2B919.73M1.1B433.62M287.61M551.84M-161.64M-90.23M164.81M316.74M62.83M96.31M-68.85M-38.08M113.08M68.31M280.94M455.6M582.91M625.09M408.46M13.1M-4.48M5.81M-4.9M34M81.4M
Cash from Investing-1.79B-1.31B-2.4B-2.7B-1.67B-2.94B-511.75M-535.16M-797.24M-744.46M-1.55B125.77M-622.21M187.39M-339.49M-474.31M-283.34M-333.71M-150.2M-377.52M-348.78M-567.28M-767.7M-819.55M-462.24M-328.49M-201.61M-14.52M-40.2M-201.1M-108M
Capital Expenditures-150.33M0-254.99M-258.62M-254.71M-145.25M-101.3M-123.38M-106.59M-74.65M-63.67M-79.75M-82.13M-47.73M-45.52M-60.13M-42.1M-21.91M-17.67M-14.49M-9.19M-29.5M-6.96M-7.91M-14.55M-8.51M-19.63M-4.03M-2.7M-4.6M-4M
Acquisitions-80.16M0-207.75M-155M752.33M-525.64M-554.13M-503M-1.18B-1.44B-7.31M-260.21M-227.88M263.34M-284.32M-120.1M-214.16M-154.92M-16.78M-8.1M043.24M0000-195.56M-129.96M000
Purchase of Investments-2.82B0-4.37B-4.94B-3.4B-3.42B-2.15B-1.05B-444.28M-941.54M-2.9B-1.64B-3.28B-2.12B-854.73M-930.07M-957.19M-726.95M-1.17B-1.65B-2.13B-2.44B-3.5B-5.24B-2.76B-1.38B-891.64M-995.45M-574.8M-904M-591M
Sale/Maturity of Investments2.06B02.4B2.63B1.39B1.14B2.22B1.13B971.01M1.71B1.33B2.04B2.71B2.36B847.25M631.55M927.05M542.13M1.09B1.3B2.23B2.32B3.46B5.22B2.75B1.4B910.32M1.12B533.1M691.9M522.3M
Other Investing-798.63M-1.31B32.17M23.08M-161.09M16.21M72.93M16.8M-42.16M5.57M92.02M61.53M262.33M-261.91M-2.16M4.45M3.06M27.94M-34.19M-4.71M-448.63M-454.19M-721.03M-797.45M-444.66M-335.9M-5.1M-6.8M4.2M15.6M-35.3M
Cash from Financing-1.12B-1.09B-297.88M-999.72M-595.31M369.77M434.56M359.32M-178.99M256.31M152.02M-74.21M-67.12M175.37M141.96M194.59M-45.61M251.61M-53.65M-208.25M58.55M-29.16M83.43M116.38M102.33M210.49M233.66M14.24M500K122.8M6.4M
Dividends Paid-618M-618M-36M-36M-36M-36M-18.4M000000000000000000000000
Share Repurchases-393.18M-429.52M-572.73M-445.48M-290.8M-206.52M-26.83M-116.31M-54.01M-110.84M-51.14M-31.49M-26.05M-57.39M-16.87M-42.91M-45.22M0-60.6M-24.21M-45.88M-15.93M-3.38M-4K0000000
Stock Issued000000000552K4.62M4.75M5.69M24.52M01.18M000000000407.53M00000
Debt Issuance (Net)-1000K-1000K1000K-1000K-1000K1000K-1000K1000K-1000K1000K1000K-1000K1000K1000K1000K1000K1000K1000K1000K-1000K1000K-1000K1000K1000K1000K-1000K1000K1000K0-1000K1000K
Other Financing-155.03M-9.88M-226.61M-193.57M-47.56M-99.49M-59.29M-65.88M-42.73M-37.53M-77.78M-24.5M-46.83M7.52M-29.31M-9.3M-13.27M-441K4.71M0-5K001.11M163K-201K-8.03M-5.47M500K144.4M-1.5M
Net Change in Cash-493.66M411.05M-139.79M-889.48M340.57M-335.7M1.72B1.1B-104.41M415.68M-891.26M669.84M-18.36M1.11B198.15M29.77M-105.23M210.12M161.92M-77.45M221.36M-45.18M6.43M-71.72M147.46M46.46M121.27M286K200K-9.7M-7.3M
Exchange Rate Effect30.28M49.77M-37.3M27.04M-103.36M-41.73M55.9M5.64M-21.05M45.3M-32.79M-32.87M-45.82M6.49M3.14M-1.82M427K9.75M-24.39M00000000000-100K
Cash at Beginning4.6B4.19B4.33B5.22B4.88B5.22B3.5B2.4B2.5B2.09B2.63B1.96B1.98B863.77M775.03M745.26M850.49M640.38M477.66M555.12M333.76M378.94M372.51M444.24M296.78M250.32M129.06M1.53M1.3M11.1M18.3M
Cash at End4.18B4.6B4.19B4.33B5.22B4.88B5.22B3.5B2.4B2.5B1.74B2.63B1.96B1.98B973.18M775.03M745.26M850.49M639.58M477.66M555.12M333.76M378.94M372.51M444.24M296.78M250.32M1.81M1.5M1.4M11M
Free Cash Flow2.19B2.55B2.34B2.53B2.45B2.13B1.64B1.15B786.26M783.88M470.95M571.4M634.66M697.8M347.01M251.19M181.19M260.56M372.48M493.83M502.4M521.75M683.73M623.54M492.81M155.96M69.58M-3.47M37.2M64M90.4M
FCF Growth %3.39%9.21%-7.48%2.99%15.31%30.1%42.19%46.36%0.3%66.45%-17.58%-9.97%-9.05%101.09%38.15%38.63%-30.46%-30.05%-24.57%-1.71%-3.71%-23.69%9.65%26.53%216%124.14%2106.34%-109.32%-41.88%-29.2%-45.05%
FCF Margin %13.2%15.4%13.96%16.09%20.78%16.48%16.98%12.09%11.31%12.93%8.39%10.64%12.36%16.14%11.57%9.55%8.14%12.59%18.84%19.89%19.94%23.71%30.23%29.81%27.84%11.16%6.36%-0.66%8.73%15.27%24.65%
FCF per Share194.75200.66179.36188.98180.76154.26118.3782.956.4755.9733.4540.6445.1555.4435.5525.8318.5226.5237.9549.4850.4352.2167.8362.1650.0518.2710.06-0.616.611.3316.07

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowDeteriorating
Top Statement Risk

Underwriting volatility and social inflation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Underwriting Cash Generation Faces Pressure

As reported in recent financial filings, Markel's underwriting cash generation has shown significant volatility, with operating cash flow plummeting to $15.9 million in 2026Q1 from a peak of $1.2 billion in 2025Q3, reflecting the impact of heightened claims activity on the firm's core float-generating engine.

The sharp contraction in operating cash flow relative to historical norms suggests that the company's ability to generate 'free' float is currently compromised by elevated loss payments. Investors should monitor whether this trend represents a temporary spike in catastrophe-related outflows or a more permanent erosion of underwriting margins due to persistent social inflation in casualty lines.

Investment Portfolio Liquidity Remains Active

Based on quarterly data, Markel continues to actively manage its investment portfolio, with 2026Q1 showing $819.5 million in purchases against $599.9 million in sales, indicating that the firm is deploying capital despite the recent deterioration in operating cash flow and overall underwriting profitability.

The consistent turnover in the investment portfolio suggests that management remains committed to its 'three-engine' capital allocation strategy, even when insurance operations are under stress. However, the reliance on portfolio sales to supplement cash needs may become a concern if underwriting losses continue to outpace premium inflows for an extended duration.

Statutory Earnings Diverge From Cash

According to the provided financial statements, the OCF/NI ratio reached a negative 0.07 in 2026Q1, a stark departure from the 3.09 ratio observed in 2025Q1, highlighting a significant disconnect between reported accounting earnings and the actual cash-generative capacity of the underlying insurance and Ventures operations.

This divergence suggests that non-cash accruals and reserve adjustments are playing an outsized role in headline profitability metrics. Analysts should be wary of relying on net income as a proxy for liquidity, as the current cash flow reality appears far more constrained than the accounting figures might otherwise imply.

Capital Return Sustainability Under Scrutiny

As evidenced by the $133.9 million in buybacks during 2026Q1 despite a net loss of $212.3 million, Markel's capital return strategy appears increasingly decoupled from current-period cash generation, raising questions about the long-term sustainability of these distributions without further liquidation of the investment portfolio.

The decision to continue share repurchases during a period of negative operating cash flow may indicate management's confidence in the long-term value of the firm, yet it warrants further investigation into the impact on statutory capital. Investors should monitor whether this capital allocation approach remains prudent if the current underwriting cycle does not show signs of stabilization.

MKL — Frequently Asked Questions

Quick answers to the most common questions about buying MKL stock.

How much cash does Markel Corporation (MKL) generate from operations?

Markel Corporation (MKL) generated $2.76B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Markel Corporation's free cash flow?

Markel Corporation (MKL) generated $2.55B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Markel Corporation's capital expenditure (CapEx)?

Markel Corporation (MKL) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Markel Corporation distribute cash to shareholders?

In 2025, Markel Corporation (MKL) returned $618.0M to shareholders via cash dividends and spent $429.5M on share repurchases. This shows the company's commitment to returning capital to its equity investors.